<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01481714</url>
  </required_header>
  <id_info>
    <org_study_id>CITRA-SPLIT</org_study_id>
    <nct_id>NCT01481714</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Split-dose Citrafleet Administered From 2 to 6 Hours Before Morning Colonoscopies</brief_title>
  <official_title>Phase IV, Prospective, Randomized Study Comparing Preparation the Day Before and Split-dose Regimen With Sodium Picosulphate/Magnesium Citrate for Morning Colonoscopies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Infante, Javier Molina, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Infante, Javier Molina, M.D.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An excellent bowel cleansing is mandatory to increase the diagnostic accuracy of colonoscopy.
      Failure to adequately cleanse the bowel for colonoscopy can lead to missed lesions, prolonged
      procedure duration and repeated procedures at earlier intervals. Emerging solid evidence is
      pointing out the need of switching from preparation the day before to regimens in which half
      or even more of the preparation is administered the same day of the procedure, which have
      extensively demonstrated to provide a significantly better cleansing, being well tolerated.
      Preparation can be fully administered the same day for afternoon procedures, whereas
      split-dose regimens fit better with morning colonoscopies. However, the ideal regimen for
      early morning colonoscopies is still to be elucidated. The second part of the preparation for
      these patients is usually recommended to be taken during sleeping time (2-3 am) on the belief
      that intake of fluids should be completely halted at least four hours prior to the
      colonoscopy procedure Sodium picosulphate is a unique orange-flavoured cleansing agent dosed
      as two powder sachets. Mayor advantages in comparison with current alternatives are
      relatively small volumes (each sachet is mixed with only 150-250 mL of water) and a more
      pleasant taste. It provides similar bowel cleansing than sodium phosphate and polyethylene
      glycol solutions administered the day before. Nonetheless, focus on split-dose regimens has
      been set on several polyethylene glycol (either high-volume or low-volume) regimens, but no
      data are available for split-dose sodium-picosulphate regarding colonoscopy in adults.

      The aim of the study is to evaluate the efficacy and safety of a sodium-picosulphate
      low-volume split-dose regimen, in which the second-half of the preparation and fluids intake
      are allowed until 2 hours for early morning colonoscopies and until 2-6 hours for morning
      colonoscopies, comparing this split-dose regimen with standard cleansing the day before with
      sodium picosulphate/magnesium citrate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Justification of the study:

      Several split-dose bowel cleansing regimens have raised over the last decade aiming to
      substitute standard preparation the day before. These split-dose regimens (based on sodium
      phosphate and polyethylene glycol solutions) have demonstrated better cleansing scores, so it
      is probably more important the time that preparation is given rather than the type of
      solution. However, the time to administer the second half of the solution in split-dose
      regimens for morning colonoscopies remains controversial. A major concern of split-dose
      regimens is the risk of aspiration pneumonia during sedation if liquids have been
      administered quite close to the procedure. As such, the second part of the preparation is
      usually given early in the morning (2-3 am) in order to have a safety-period of at least four
      hours prior to the colonoscopy. However, this is quite disturbing for patients and may hamper
      the adherence to further colonoscopies. Furthermore, On the other hand, no study addressing
      the role of split-dose Citrafleet has been published to date

      Therefore it is necessary to make a controlled clinical trial to directly compare &quot;the day
      before&quot; and &quot; split-dose&quot; regimens with Citrafleet for morning colonoscopies. In order to
      maximize the efficacy of the split-dose regimens, the time period between fluids intake and
      the colonoscopy will be shortened up up to 2 hours for morning colonoscopies scheduled from 9
      to 11 am and up to 3 hours for that scheduled after 11 am. The results of this study will
      conclude whether there is still room for improvement in bowel cleansing for morning
      colonoscopies, using more palatable low-volume solutions without interrupting sleep time.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">March 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Degree of bowel cleansing (Boston Scale 0-3) in each anatomical segment of the colon</measure>
    <time_frame>4 months</time_frame>
    <description>Boston Scale: 3: excellent; 2: good ; 1: fair; 0: poor. Anatomical segments of the colon: rectum, sigmoid colon, descending colon, transverse colon, ascending colon and cecum</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of aspiration bronchopneumonia</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adenoma detection rate</measure>
    <time_frame>4 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Bowel Cleansing</condition>
  <condition>Colonoscopy</condition>
  <arm_group>
    <arm_group_label>Sodium Picosulphate preparation the day before</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Preparation the day before of the procedure using sodium picosulphate:
A sachet mixed with 250 mL of water at 18:00 pm
A sachet mixed with 250 mL of water at 21:00 pm
A minimum of 4 litres of fluid were recommended throughout the preparation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Split-dose sodium picosulphate preparation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The day before the procedure:
- A sachet mixed with 250 mL of water at 18:00 pm, followed by 2 litres of clear liquids
The day of the procedure:
A sachet administered at 5:45 am, followed by 1,5 litres of fluid intake up to 7 am for colonoscopies scheduled from 9 to 11 am.
A sachet administered at 6:45 am, followed by 1,5 litres of fluid intake up to 8 for colonoscopies scheduled after 11 am.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium picosulphate, magnesium oxid and citric acid</intervention_name>
    <description>A sachet mixed with 250 mL of water at 18:00 pm
A sachet mixed with 250 mL of water at 21:00 pm
A minimum of 4 litres of fluid were recommended throughout the preparation</description>
    <arm_group_label>Sodium Picosulphate preparation the day before</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium picosulphate/magnesium oxide and citric acid</intervention_name>
    <description>The day before the procedure:
- A sachet mixed with 250 mL of water at 18:00 pm, followed by 2 litres of clear liquids
The day of the procedure:
A sachet administered at 5:45 am, followed by 1,5 litres of fluid intake up to 7 am for colonoscopies scheduled from 9 to 11 am.
A sachet administered at 6:45 am, followed by 1,5 litres of fluid intake up to 8 for colonoscopies scheduled after 11 am.</description>
    <arm_group_label>Split-dose sodium picosulphate preparation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients undergoing routine elective colonoscopy

        Exclusion Criteria:

          -  pregnant or lactating women

          -  age less than 18 years

          -  significant gastroparesis or gastric outlet obstruction or ileus

          -  known or suspected bowel obstruction or perforation

          -  phenylketonuria or glucose-6-phosphate dehydrogenase deficiency

          -  severe chronic renal failure (creatinine clearance &lt; 30 mL/minute)

          -  severe congestive heart failure (New York Heart Association [NYHA] class III or IV)

          -  dehydration

          -  severe acute inflammatory disease

          -  compromised swallowing reflex or mental status

          -  uncontrolled hypertension (systolic blood pressure &gt; 170 mm Hg ad/or diastolic blood
             pressure &gt; 100 mm Hg)

          -  toxic colitis

          -  megacolon
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Javier Molina-Infante, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital San Pedro de Alcantara, Caceres, Spain</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Javier Molina-Infante, MD</last_name>
    <phone>0034627430248</phone>
    <email>xavi_molina@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital San Pedro de Alcantara</name>
      <address>
        <city>Caceres</city>
        <zip>10003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Javier Molina-Infante, MD</last_name>
      <email>xavi_molina@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Javier Molina-Infante</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gema Vinagre-Rodriguez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Moises Hernandez-Alonso</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carmen Due√±as-Sadornil</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miguel Fernandez-Bermejo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jose M Mateos-Rodriguez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elisa Martin-Noguerol</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jesus M Gonzalez-Santiago</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carmen Martinez-Alcala</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Hoy SM, Scott LJ, Wagstaff AJ. Sodium picosulfate/magnesium citrate: a review of its use as a colorectal cleanser. Drugs. 2009;69(1):123-36. doi: 10.2165/00003495-200969010-00009. Review.</citation>
    <PMID>19192941</PMID>
  </reference>
  <reference>
    <citation>Love J, Bernard EJ, Cockeram A, Cohen L, Fishman M, Gray J, Morgan D. A multicentre, observational study of sodium picosulfate and magnesium citrate as a precolonoscopy bowel preparation. Can J Gastroenterol. 2009 Oct;23(10):706-10. Erratum in: Can J Gastroenterol. 2009 Nov;23(11):784.</citation>
    <PMID>19826647</PMID>
  </reference>
  <reference>
    <citation>Turner D, Benchimol EI, Dunn H, Griffiths AM, Frost K, Scaini V, Avolio J, Ling SC. Pico-Salax versus polyethylene glycol for bowel cleanout before colonoscopy in children: a randomized controlled trial. Endoscopy. 2009 Dec;41(12):1038-45. doi: 10.1055/s-0029-1215333. Epub 2009 Dec 4.</citation>
    <PMID>19967619</PMID>
  </reference>
  <reference>
    <citation>Hookey LC, Vanner SJ. Pico-salax plus two-day bisacodyl is superior to pico-salax alone or oral sodium phosphate for colon cleansing before colonoscopy. Am J Gastroenterol. 2009 Mar;104(3):703-9. doi: 10.1038/ajg.2008.167. Epub 2009 Feb 17.</citation>
    <PMID>19223885</PMID>
  </reference>
  <reference>
    <citation>Worthington J, Thyssen M, Chapman G, Chapman R, Geraint M. A randomised controlled trial of a new 2 litre polyethylene glycol solution versus sodium picosulphate + magnesium citrate solution for bowel cleansing prior to colonoscopy. Curr Med Res Opin. 2008 Feb;24(2):481-8. doi: 10.1185/030079908X260844 .</citation>
    <PMID>18179734</PMID>
  </reference>
  <reference>
    <citation>Renaut AJ, Raniga S, Frizelle FA, Perry RE, Guilford L. A randomized controlled trial comparing the efficacy and acceptability of phospo-soda buffered saline (Fleet) with sodium picosulphate/magnesium citrate (Picoprep) in the preparation of patients for colonoscopy. Colorectal Dis. 2008 Jun;10(5):503-5. Epub 2007 Sep 13.</citation>
    <PMID>17868404</PMID>
  </reference>
  <reference>
    <citation>Park SS, Sinn DH, Kim YH, Lim YJ, Sun Y, Lee JH, Kim JY, Chang DK, Son HJ, Rhee PL, Rhee JC, Kim JJ. Efficacy and tolerability of split-dose magnesium citrate: low-volume (2 liters) polyethylene glycol vs. single- or split-dose polyethylene glycol bowel preparation for morning colonoscopy. Am J Gastroenterol. 2010 Jun;105(6):1319-26. doi: 10.1038/ajg.2010.79. Epub 2010 May 18.</citation>
    <PMID>20485282</PMID>
  </reference>
  <reference>
    <citation>Matro R, Shnitser A, Spodik M, Daskalakis C, Katz L, Murtha A, Kastenberg D. Efficacy of morning-only compared with split-dose polyethylene glycol electrolyte solution for afternoon colonoscopy: a randomized controlled single-blind study. Am J Gastroenterol. 2010 Sep;105(9):1954-61. doi: 10.1038/ajg.2010.160. Epub 2010 Apr 20.</citation>
    <PMID>20407434</PMID>
  </reference>
  <reference>
    <citation>Seo EH, Kim TO, Kim TG, Joo HR, Park MJ, Park J, Park SH, Yang SY, Moon YS. Efficacy and tolerability of split-dose PEG compared with split-dose aqueous sodium phosphate for outpatient colonoscopy: a randomized, controlled trial. Dig Dis Sci. 2011 Oct;56(10):2963-71. doi: 10.1007/s10620-011-1772-1. Epub 2011 Jun 9.</citation>
    <PMID>21656179</PMID>
  </reference>
  <reference>
    <citation>Kilgore TW, Abdinoor AA, Szary NM, Schowengerdt SW, Yust JB, Choudhary A, Matteson ML, Puli SR, Marshall JB, Bechtold ML. Bowel preparation with split-dose polyethylene glycol before colonoscopy: a meta-analysis of randomized controlled trials. Gastrointest Endosc. 2011 Jun;73(6):1240-5. doi: 10.1016/j.gie.2011.02.007.</citation>
    <PMID>21628016</PMID>
  </reference>
  <reference>
    <citation>Huffman M, Unger RZ, Thatikonda C, Amstutz S, Rex DK. Split-dose bowel preparation for colonoscopy and residual gastric fluid volume: an observational study. Gastrointest Endosc. 2010 Sep;72(3):516-22. doi: 10.1016/j.gie.2010.03.1125. Epub 2010 Jun 19.</citation>
    <PMID>20646700</PMID>
  </reference>
  <reference>
    <citation>Di Palma JA, Rodriguez R, McGowan J, Cleveland Mv. A randomized clinical study evaluating the safety and efficacy of a new, reduced-volume, oral sulfate colon-cleansing preparation for colonoscopy. Am J Gastroenterol. 2009 Sep;104(9):2275-84. doi: 10.1038/ajg.2009.389. Epub 2009 Jul 7.</citation>
    <PMID>19584830</PMID>
  </reference>
  <reference>
    <citation>Gupta T, Mandot A, Desai D, Abraham P, Joshi A, Shah S. Comparison of two schedules (previous evening versus same morning) of bowel preparation for colonoscopy. Endoscopy. 2007 Aug;39(8):706-9.</citation>
    <PMID>17661245</PMID>
  </reference>
  <reference>
    <citation>Longcroft-Wheaton G, Bhandari P. Same-day bowel cleansing regimen is superior to a split-dose regimen over 2 days for afternoon colonoscopy: results from a large prospective series. J Clin Gastroenterol. 2012 Jan;46(1):57-61. doi: 10.1097/MCG.0b013e318233a986.</citation>
    <PMID>22064553</PMID>
  </reference>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 25, 2011</study_first_submitted>
  <study_first_submitted_qc>November 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2011</study_first_posted>
  <last_update_submitted>November 28, 2011</last_update_submitted>
  <last_update_submitted_qc>November 28, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 29, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sodium picosulphate</keyword>
  <keyword>Split-dose</keyword>
  <keyword>Bowel cleansing</keyword>
  <keyword>colonoscopy</keyword>
  <keyword>Degree of bowel cleansing during colonoscopy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Picosulfate sodium</mesh_term>
    <mesh_term>Magnesium Oxide</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>March 14, 2017</submitted>
    <returned>April 24, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

